- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
OptiMetrix acquired for new technology
Los Alamos, NM-Advanced Refractive Technologies, which develops and markets innovative ophthalmic applications, acquired OptiMetrix Technologies Inc., a subsidiary of UTEK Corp., in a stock transfer.
Los Alamos, NM-Advanced Refractive Technologies, which develops and markets innovative ophthalmic applications, acquired OptiMetrix Technologies Inc., a subsidiary of UTEK Corp., in a stock transfer.
OptiMetrix owns the exclusive license to a patented technology to detect cataract formation.
Developed at the Los Alamos National Laboratory, the technology uses fiber-optic, OMA-based instrumentation as an in vivo diagnostic tool for the human ocular lens.
Advanced Refractive Technologies is also developing the Accupulse cataract emulsifier, a device that uses pulsed waterjet technology to remove cataracts.
